Pulmonary Arterial Hypertension Clinical Trials

A listing of Pulmonary Arterial Hypertension medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 155 clinical trials
Effects of DHEA in Pulmonary Hypertension (EDIPHY)

imaging at 18 weeks compared to placebo and to assess side effects and safety in pulmonary arterial hypertension.

forced expiratory volume
pulmonary function test
hypertension
ventilation perfusion lung scan
pulmonary disease
  • 17 views
  • 27 Apr, 2022
  • 1 location
A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH

This single-arm, Phase 3, 2-part, open-label, multicenter study aims to demonstrate the safety and tolerability of L606 in patients with PAH switching from a stable Tyvaso dose. The study will

  • 1 views
  • 21 Mar, 2022
  • 1 location
Safety, Tolerability, & Pharmacokinetics Study of Single & Multiple Inhaled Doses of Imatinib Inhalation Solution

This is a randomised, double-blind, placebo-controlled, dose escalation study to evaluate the safety, tolerability, and PK of single and multiple inhaled doses of imatinib inhalation solution (AER-901) in healthy adult volunteers. This study consists of 2 parts and an optional third part: Part A: double-blind, placebo-controlled, single ascending dose (SAD). …

Accepts healthy volunteers
  • 0 views
  • 23 Mar, 2022
  • 1 location
ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy

Pulmonary Arterial Hypertension or PAH is a progressive condition for which there is no cure. Even with substantial pharmacologic advances in the modern treatment era, survival still remains

  • 100 views
  • 25 Mar, 2021
  • 1 location
COMPression of Left Main coRonary artEry in patientS With Pulmonary Arterial Hypertension aSymptomatIc fOr aNgina (COMPRESSION)

The prevalence of critical ab extrinsic compression of left main coronary artery (LMCA) is very high in patients with pulmonary arterial hypertension (PAH) symptomatic for angina (up to 40

  • 0 views
  • 16 Jun, 2022
  • 1 location
  • 0 views
  • 21 Oct, 2022
  • 9 locations
Open-Label, Randomized Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Different Formulations of an IP Receptor Agonist

The purpose of the study is to assess safety and tolerability of prostacyclin receptor agonist formulation in treatment period 1 and with different formulation of prostacyclin receptor agonist in treatment period 2.

Accepts healthy volunteers
  • 0 views
  • 23 Oct, 2022
  • 1 location
A Randomized, Participant- and Investigator-blinded, Placebo-controlled Study to Investigate Efficacy, Safety, and Tolerability of LTP001 in Participants With Pulmonary Arterial Hypertension

The purpose of this study is to explore the efficacy and safety of LTP001 in participants with pulmonary arterial hypertension (PAH) to determine if LTP001 has an adequate clinical profile to

  • 0 views
  • 23 Oct, 2022
  • 5 locations
Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial Hypertension: a Multicenter, Randomized, Double-blind, Placebo-controlled Study (TAPE)

An Investigator initiated trial (IIT) using a prospective, randomized, double-blind, parallel group, placebo-controlled, clinical study design.

  • 0 views
  • 11 Oct, 2022
  • 1 location
  • 0 views
  • 07 Oct, 2022
  • 1 location